학술논문
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis
Document Type
Article
Author
Source
In JAAD International March 2022 6:27-36
Subject
Language
ISSN
2666-3287